Abstract
Tuberculosis is a neglected disease caused by Mycobacterium tuberculosis. Some evidence suggests its existence since thousands of years and today it still represents a public health problem. Current treatment presents serious problems such as adverse effects, high cost, long term, besides the emergence of resistant strains. Therefore the search for new antimicrobials is still in need. In this work we reviewed tuberculosis treatment as well as the synthesis of the current drugs and new synthetic derivatives that have been developed against M. tuberculosis. In this context we explored the medicinal chemistry and molecular modeling strategies as important tools to guide the rational design and synthesis of novel chemotherapeutic agents for use in tuberculosis.
Keywords: Antimicrobial, medicinal chemistry, Mycobaterium tuberculosis, resistance, topoisomerase inhibitors, tuberculosis.
Current Drug Therapy
Title:Tuberculosis, an Old Disease Lacking New Therapeutic Drugs
Volume: 8 Issue: 2
Author(s): Paula A. Abreu, Cid A. Medeiros, Julio C. Borges, Alice M.R. Bernardino, Carlos R. Rodrigues and Helena C. Castro
Affiliation:
Keywords: Antimicrobial, medicinal chemistry, Mycobaterium tuberculosis, resistance, topoisomerase inhibitors, tuberculosis.
Abstract: Tuberculosis is a neglected disease caused by Mycobacterium tuberculosis. Some evidence suggests its existence since thousands of years and today it still represents a public health problem. Current treatment presents serious problems such as adverse effects, high cost, long term, besides the emergence of resistant strains. Therefore the search for new antimicrobials is still in need. In this work we reviewed tuberculosis treatment as well as the synthesis of the current drugs and new synthetic derivatives that have been developed against M. tuberculosis. In this context we explored the medicinal chemistry and molecular modeling strategies as important tools to guide the rational design and synthesis of novel chemotherapeutic agents for use in tuberculosis.
Export Options
About this article
Cite this article as:
Abreu A. Paula, Medeiros A. Cid, Borges C. Julio, Bernardino M.R. Alice, Rodrigues R. Carlos and Castro C. Helena, Tuberculosis, an Old Disease Lacking New Therapeutic Drugs, Current Drug Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/1574885511308020003
DOI https://dx.doi.org/10.2174/1574885511308020003 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases
Recent Patents on Anti-Infective Drug Discovery Host-Directed Therapeutics against Mycobacterial Infections
Current Pharmaceutical Design Diagnosis and Treatment of Pulmonary Fungal Infections in Critically Ill Patients
Current Respiratory Medicine Reviews Supercritical Fluid Particle Design of DPI Formulations (Review)
Current Pharmaceutical Design The Use of Fluorescence Polarization Assays for the Detection of Infectious Diseases
Combinatorial Chemistry & High Throughput Screening Peptidylprolyl Cis / Trans Isomerases (Immunophilins): Biological Diversity - Targets - Functions
Current Topics in Medicinal Chemistry The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Developments of Corey-Chaykovsky in Organic Reactions and Total Synthesis of Natural Products
Current Organic Synthesis HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Pharmacogenetics Research Developments in Africa: A Focus on Malawi
Current Pharmacogenomics and Personalized Medicine Immune Modulation by Regulatory T Cells in Helicobacter pylori-Associated Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Editorial: Anti-Infective Drug Discovery Based on Diversified Plant Natural Compounds
Current Organic Chemistry Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease
Current Pharmaceutical Design New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice
Current Pharmaceutical Design Non-Viral Gene Delivery to the Lungs
Current Gene Therapy EHDA Spraying: A Multi-Material Nano-Engineering Route
Current Pharmaceutical Design Computational Medicinal Chemistry for Rational Drug Design: Identification of Novel Chemical Structures with Potential Anti-Tuberculosis Activity
Current Topics in Medicinal Chemistry Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections
Current Topics in Medicinal Chemistry